ArticleOnco2022
ERBB1/EGFR and JAK3 Tyrosine Kinases as Potential Therapeutic Targets in High-Risk Multiple Myeloma.
Fatih M Uckun et al.PubMed ↗Full text ↗Publisher ↗
No numbers read from the abstract.
4 papers cite it
this papercites it
ArticleOnco2022
Fatih M Uckun et al.PubMed ↗Full text ↗Publisher ↗
No numbers read from the abstract.